Accessing simply-substituted 4-hydroxytetrahydroisoquinolines via Pomeranz–Fritsch–Bobbitt reaction with non-activated and moderately-activated systems

por Mottinelli, Marco, Leese, Mathew P, Potter, Barry V L
Publicado 2017

Steroidomimetic Tetrahydroisoquinolines for the Design of New Microtubule Disruptors

por Leese, Mathew P., Jourdan, Fabrice, Dohle, Wolfgang, Kimberley, Meriel R., Thomas, Mark P., Bai, Ruoli, Hamel, Ernest, Ferrandis, Eric, Potter, Barry V. L.
Publicado 2011

Synthesis, Anti-tubulin and Antiproliferative SAR of Steroidomimetic Dihydroisoquinolinones

por Leese, Mathew P, Jourdan, Fabrice L, Major, Meriel R, Dohle, Wolfgang, Thomas, Mark P, Hamel, Ernest, Ferrandis, Eric, Mahon, Mary F, Newman, Simon P, Purohit, Atul, Potter, Barry V L
Publicado 2014

Targeted NF1 cancer therapeutics with multiple modes of action: small molecule hormone-like agents resembling the natural anticancer metabolite, 2-methoxyoestradiol

por Shen, Yu-chi, Upadhyayula, Ravi, Cevallos, Stephanie, Messick, Ryan J, Hsia, Tammy, Leese, Mathew P, Jewett, Douglas M, Ferrer-Torres, Daysha, Roth, Therese M, Dohle, Wolfgang, Potter, Barry V L, Barald, Kate F
Publicado 2015